Clinical Study Results
These treatment groups are shown in the table below.
Dose of Dose of Dose of
Group MEDI0562 durvalumab tremelimumab
Group 1 • 2.25 mg • 1500 mg
None
(3 participants) • Every 2 weeks • Every 4 weeks
Group 2 • 7.5 mg • 1500 mg
None
(16 participants) • Every 2 weeks • Every 4 weeks
Group 3 • 22.5 mg • 1500 mg
None
(8 participants) • Every 2 weeks • Every 4 weeks
• 75 mg
Group 4 • 2.25 mg
None • Every 4 weeks,
(5 participants) • Every 2 weeks
up to 4 doses
• 225 mg
Group 5 • 2.25 mg
None • Every 4 weeks,
(11 participants) • Every 2 weeks
up to 4 doses
• 225 mg
Group 6 • 7.5 mg
None • Every 4 weeks,
(3 participants) • Every 2 weeks
up to 4 doses
• 225 mg
Group 7 • 22.5 mg
None • Every 4 weeks,
(7 participants) • Every 2 weeks
up to 4 doses
• 75 mg
Group 8 • 22.5 mg
None • Every 4 weeks,
(5 participants) • Every 2 weeks
up to 4 doses
4